ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
118.532,68
-1,33%
S&P 500
5.942,47
1,26%
US Dollar vs BRL
6,1822
0,00%
Bitcoin
97.775,94
-0,45%
Brent Oil
76,495
0,00%
As Melhores Corretoras Online
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Rani Therapeutics Holdings Inc (RANI)

  7. Rani Therapeutics Holdings Inc (RANI) Notícias

RANI

Rani Therapeutics (RANI)

Rani Therapeutics Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:RANI
DataHoraFonteTítuloCódigoCompanhia
17/12/202419:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RANIRani Therapeutics Holdings Inc
14/11/202410:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RANIRani Therapeutics Holdings Inc
14/11/202410:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RANIRani Therapeutics Holdings Inc
14/11/202410:00GlobeNewswire Inc.Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
07/11/202418:05GlobeNewswire Inc.Rani Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:RANIRani Therapeutics Holdings Inc
17/10/202409:00GlobeNewswire Inc.Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin TriagonistNASDAQ:RANIRani Therapeutics Holdings Inc
16/10/202407:04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RANIRani Therapeutics Holdings Inc
15/10/202409:30GlobeNewswire Inc.Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing WarrantsNASDAQ:RANIRani Therapeutics Holdings Inc
08/10/202417:05GlobeNewswire Inc.Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:RANIRani Therapeutics Holdings Inc
03/09/202417:05GlobeNewswire Inc.Rani Therapeutics to Participate in September Investor ConferencesNASDAQ:RANIRani Therapeutics Holdings Inc
06/08/202417:05GlobeNewswire Inc.Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
29/07/202417:05GlobeNewswire Inc.Rani Therapeutics to Participate in August Investor ConferencesNASDAQ:RANIRani Therapeutics Holdings Inc
22/07/202409:30GlobeNewswire Inc.Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct OfferingNASDAQ:RANIRani Therapeutics Holdings Inc
24/06/202408:00GlobeNewswire Inc.Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity TreatmentNASDAQ:RANIRani Therapeutics Holdings Inc
14/05/202409:00GlobeNewswire Inc.Rani Therapeutics to Participate in May Investor ConferencesNASDAQ:RANIRani Therapeutics Holdings Inc
09/05/202409:00GlobeNewswire Inc.Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024NASDAQ:RANIRani Therapeutics Holdings Inc
06/05/202417:05GlobeNewswire Inc.Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
20/03/202417:05GlobeNewswire Inc.Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
15/03/202417:05GlobeNewswire Inc.Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:RANIRani Therapeutics Holdings Inc
05/02/202410:00GlobeNewswire Inc.Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111)NASDAQ:RANIRani Therapeutics Holdings Inc
14/12/202310:00GlobeNewswire Inc.Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin TriagonistNASDAQ:RANIRani Therapeutics Holdings Inc
08/11/202318:05GlobeNewswire Inc.Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
01/11/202317:05GlobeNewswire Inc.Rani Therapeutics Announces Strategic Program Prioritization, Expansion of Manufacturing and Plans to Streamline Business Operations to Support Near-Term Value Drivers and Long-Term Growth of the RaniPill® Technology Platform; Reports Preliminary Third QuNASDAQ:RANIRani Therapeutics Holdings Inc
25/10/202309:00GlobeNewswire Inc.The RaniPill® Capsule, Rani Therapeutics’ Oral Delivery Platform, was Well-Tolerated in 60-Day, Repeat-Administration, GLP Safety StudyNASDAQ:RANIRani Therapeutics Holdings Inc
19/10/202317:05GlobeNewswire Inc.Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical StudyNASDAQ:RANIRani Therapeutics Holdings Inc
12/10/202317:05GlobeNewswire Inc.Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral ResearchNASDAQ:RANIRani Therapeutics Holdings Inc
18/09/202309:00GlobeNewswire Inc.Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill® Containing Ustekinumab Biosimilar, CT-P43)NASDAQ:RANIRani Therapeutics Holdings Inc
07/09/202317:05GlobeNewswire Inc.Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical StudiesNASDAQ:RANIRani Therapeutics Holdings Inc
11/08/202317:05GlobeNewswire Inc.Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
08/08/202317:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RANIRani Therapeutics Holdings Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:RANI

Seu Histórico Recente

BIT
KK
Kruso Kapital
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados